50% of millennials would pick CBD oil over prescriptions for mental health
Eos Scientific has commissioned research across a sample of more than 2000 UK adults exploring the growing shift in health-conscious millennials seeking CBD oil over prescriptions for mental health.
Addressing how cannabis businesses are banked: Room for improvement?
With attention turning in the U.S. and elsewhere to how cannabis businesses are banked, John Binns, Partner at BCL Solicitors LLP, gets into the weeds of how UK banks have been addressing the issue, as well as the prospects for improvement.
What is the Europe Canna Expo?
Kristina Spionjak discusses what will happen at Europe Canna Expo 2020, and reflects on opportunities for the medical cannabis industry.
CBD oil revolution: Introducing what it is and why the hype?
Open Access Government delve into the CBD oil revolution in this introduction to CBD which explores the difference between CBD and THC, as well as a range of benefits and safety precautions for cannabidiol use in cancer patients and pregnant women.
A focus on the rise of cannabidiol (CBD)
George Thomas, Managing Director of Goodbody Botanicals, part of Sativa Group Plc, turn our thoughts towards the undoubted rise of cannabidiol (CBD).
Seeding the future of the British hemp industry
Rebekah Shaman, Managing Director at British Hemp Alliance takes a close look at the future of the British hemp industry in this article.
Healing with cannabinoids: MS and Prostate Cancer
Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
What are the most common myths about CBD?
Here, Paul Segal, chairman and co-founder of Symtomax, details what the most common myths about CBD are.
Why is it so hard to determine which CBD products to buy?
Jade Mansfield from British CBD Company, explains why it is so hard to know which CBD products to buy since its growth in popularity.
European Medicines Agency and orphan designation
Here, we discover that the European Medicines Agency works to foster scientific excellence in the evaluation and supervision of medicines for the benefit of public and animal health in the European Union.
The pharmaceutical industry in Europe
Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.
Medical use of cannabinoids and marijuana
In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.
A World Health Organization perspective on cannabidiol (CBD)
Here, we discover the World Health Organization perspective on cannabidiol (CBD), including how there has been a shift in how CBD is socially perceived following reports and recommendations.
The medical cannabis market in Denmark & Europe
Investment Manager at the Ministry of Foreign Affairs of Denmark, Michael Prytz, charts the rapid development of the medical cannabis market in Europe and provides a look at the Danish model in this vein.
Bioavailibity: Oils, capsules, vapes, gummies and balms
Here, we have a brief look at the different methods of using CBD, and how each method affects bioavailability.
What next for the UK’s cannabis laws?
John Binns, Partner at BCL Solicitors LLP looks at the UK’s cannabis laws and how they could be improved.
IP protection in fast-moving global markets: Medical cannabis & CBD
Laura Clews, Managing Associate at IP attorneys Mathys & Squire, analyses the protection for innovative new products in the medical cannabis & CBD sector.
From Cannabis flower to final products: Extractions for Phytopharmaceuticals
Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.
Medicinal cannabis: What the UK can learn from Denmark
Spectrum Therapeutics UK lifts the lid here on a pilot analysis of medicinal cannabis use that will run in Denmark until January 2022.
Cannabinoids in Medicine Part 3: Psoriasis and Rheumatoid Arthritis
Following the first two articles that discussed the treatment of cancer and pain, this third piece will focus on the use of cannabinoids to treat psoriasis and rheumatoid arthritis.